Advertisement

Index by Author

January 1999; 22 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aaser, E

    • Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care January 1999 22:45-49; doi:10.2337/diacare.22.1.45

  2. Arcari, R

    • Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care January 1999 22:50-55; doi:10.2337/diacare.22.1.50

  3. Asp, N G

    • Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care January 1999 22:10-18; doi:10.2337/diacare.22.1.10

  4. Aubert, R E

    • Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diabetes Care January 1999 22:1-6; doi:10.2337/diacare.22.1.1

B

  1. Barnes, R B

    • Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care January 1999 22:141-146; doi:10.2337/diacare.22.1.141

  2. Benhamou, P Y

    • Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care January 1999 22:19-26; doi:10.2337/diacare.22.1.19

  3. Berglund, L

    • Peripheral atherosclerosis and serum lipoprotein(a) in diabetes. Diabetes Care January 1999 22:93-98; doi:10.2337/diacare.22.1.93

  4. Berne, C

    • Peripheral atherosclerosis and serum lipoprotein(a) in diabetes. Diabetes Care January 1999 22:93-98; doi:10.2337/diacare.22.1.93

  5. Björck, I E

    • Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care January 1999 22:10-18; doi:10.2337/diacare.22.1.10

  6. Bjørnholt, J V

    • Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care January 1999 22:45-49; doi:10.2337/diacare.22.1.45

  7. Black, S A

    • Increased health burden associated with comorbid depression in older diabetic Mexican Americans. Results from the Hispanic Established Population for the Epidemiologic Study of the Elderly survey. Diabetes Care January 1999 22:56-64; doi:10.2337/diacare.22.1.56

  8. Bloomgarden, Z T

    • American Diabetes Association Annual Meeting, 1998. Treatment of type 2 diabetes. Diabetes Care January 1999 22:170-174; doi:10.2337/diacare.22.1.170

  9. Boomsma, L J

    • Prevalence of deafness is increased in patients with type 2 diabetes in The Netherlands. Diabetes Care January 1999 22:180; doi:10.2337/diacare.22.1.180

  10. Borra, M

    • Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care January 1999 22:50-55; doi:10.2337/diacare.22.1.50

  11. Boulton, A J

    • Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care January 1999 22:157-162; doi:10.2337/diacare.22.1.157

  12. Boyages, S

    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care January 1999 22:119-124; doi:10.2337/diacare.22.1.119

  13. Boyko, E J

    • Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care January 1999 22:65-70; doi:10.2337/diacare.22.1.65
    • Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care January 1999 22:157-162; doi:10.2337/diacare.22.1.157

  14. Brismar, K

    • Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care January 1999 22:147-151; doi:10.2337/diacare.22.1.147

  15. Brown, J B

    • First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization. Diabetes Care January 1999 22:38-44; doi:10.2337/diacare.22.1.38

  16. Bruno, G

    • Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care January 1999 22:50-55; doi:10.2337/diacare.22.1.50

  17. Burge, M R

    • Optimal administration of lispro insulin in hyperglycemic type 1 diabetes. Diabetes Care January 1999 22:133-136; doi:10.2337/diacare.22.1.133

C

  1. Carta, Q

    • Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care January 1999 22:50-55; doi:10.2337/diacare.22.1.50

  2. Carter, J

    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care January 1999 22:119-124; doi:10.2337/diacare.22.1.119

  3. Cattalini, N

    • Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care January 1999 22:176-177; doi:10.2337/diacare.22.1.176a

  4. Cavaghan, M K

    • Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care January 1999 22:141-146; doi:10.2337/diacare.22.1.141

  5. Chan, N N

    • Lactic acidosis with therapeutic metformin blood level in a low-risk diabetic patient. Diabetes Care January 1999 22:178; doi:10.2337/diacare.22.1.178b

  6. Chessler, S D

    • Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care January 1999 22:65-70; doi:10.2337/diacare.22.1.65

  7. Chiarelli, F

    • Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care January 1999 22:7-9; doi:10.2337/diacare.22.1.7

  8. Chiari, G

    • Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care January 1999 22:7-9; doi:10.2337/diacare.22.1.7

  9. Choi, H

    • Social environment and year of birth influence type 1 diabetes risk for African-American and Latino children. Diabetes Care January 1999 22:78-85; doi:10.2337/diacare.22.1.78

  10. Cocciolo, M

    • Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care January 1999 22:176-177; doi:10.2337/diacare.22.1.176a

  11. Colagiuri, S

    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care January 1999 22:119-124; doi:10.2337/diacare.22.1.119

  12. Colli, A

    • Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care January 1999 22:176-177; doi:10.2337/diacare.22.1.176a

  13. Cordonnier, D

    • Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care January 1999 22:19-26; doi:10.2337/diacare.22.1.19

  14. Costi, G

    • Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care January 1999 22:7-9; doi:10.2337/diacare.22.1.7

D

  1. Dahlén, G

    • Peripheral atherosclerosis and serum lipoprotein(a) in diabetes. Diabetes Care January 1999 22:93-98; doi:10.2337/diacare.22.1.93

  2. Darko, D

    • Lactic acidosis with therapeutic metformin blood level in a low-risk diabetic patient. Diabetes Care January 1999 22:178; doi:10.2337/diacare.22.1.178b

  3. del Aguila, M

    • Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care January 1999 22:157-162; doi:10.2337/diacare.22.1.157

  4. Denis, B

    • Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care January 1999 22:19-26; doi:10.2337/diacare.22.1.19

  5. De Salvia, A

    • Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care January 1999 22:50-55; doi:10.2337/diacare.22.1.50

  6. Donnelly, T

    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care January 1999 22:119-124; doi:10.2337/diacare.22.1.119

  7. Drum, M

    • Social environment and year of birth influence type 1 diabetes risk for African-American and Latino children. Diabetes Care January 1999 22:78-85; doi:10.2337/diacare.22.1.78

  8. Dunger, D B

    • Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Diabetes Care January 1999 22:27-32; doi:10.2337/diacare.22.1.27

E

  1. Edge, J A

    • Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Diabetes Care January 1999 22:27-32; doi:10.2337/diacare.22.1.27

  2. Ehrmann, D A

    • Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care January 1999 22:141-146; doi:10.2337/diacare.22.1.141

  3. Elliott, T

    • Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care January 1999 22:112-118; doi:10.2337/diacare.22.1.112

  4. Erikssen, G

    • Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care January 1999 22:45-49; doi:10.2337/diacare.22.1.45

  5. Erikssen, J

    • Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care January 1999 22:45-49; doi:10.2337/diacare.22.1.45

  6. Ettinger, B

    • First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization. Diabetes Care January 1999 22:38-44; doi:10.2337/diacare.22.1.38

F

  1. Fagrell, B

    • Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care January 1999 22:147-151; doi:10.2337/diacare.22.1.147

  2. Fagret, D

    • Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care January 1999 22:19-26; doi:10.2337/diacare.22.1.19

  3. Falkner, B

    • Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions. Diabetes Care January 1999 22:71-77; doi:10.2337/diacare.22.1.71

  4. Francobandiera, F

    • Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care January 1999 22:176-177; doi:10.2337/diacare.22.1.176a

  5. Fujimoto, W Y

    • Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care January 1999 22:65-70; doi:10.2337/diacare.22.1.65

G

  1. Ghizzoni, L

    • Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care January 1999 22:7-9; doi:10.2337/diacare.22.1.7

  2. Giacalone, T

    • Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care January 1999 22:7-9; doi:10.2337/diacare.22.1.7

  3. Granfeldt, Y E

    • Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care January 1999 22:10-18; doi:10.2337/diacare.22.1.10

  4. Grosso, N

    • Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care January 1999 22:50-55; doi:10.2337/diacare.22.1.50

  5. Gunton, J E

    • Heterozygous hemoglobin Hamadan affects HbA1c assay. Diabetes Care January 1999 22:177; doi:10.2337/diacare.22.1.177

H

  1. Halimi, S

    • Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care January 1999 22:19-26; doi:10.2337/diacare.22.1.19

  2. Hammoud, T

    • Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care January 1999 22:19-26; doi:10.2337/diacare.22.1.19

  3. Harris, D A

    • Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Diabetes Care January 1999 22:27-32; doi:10.2337/diacare.22.1.27

  4. Herman, W H

    • Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diabetes Care January 1999 22:1-6; doi:10.2337/diacare.22.1.1

  5. Hopkins, H

    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care January 1999 22:119-124; doi:10.2337/diacare.22.1.119

I

  1. Imperial, J

    • Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care January 1999 22:141-146; doi:10.2337/diacare.22.1.141

  2. Ishikawa, Y

    • Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care January 1999 22:152-156; doi:10.2337/diacare.22.1.152

J

  1. Järvi, A E

    • Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care January 1999 22:10-18; doi:10.2337/diacare.22.1.10

  2. Jervell, J

    • Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care January 1999 22:45-49; doi:10.2337/diacare.22.1.45

  3. Johansen, K

    • Efficacy of metformin in the treatment of NIDDM. Meta-analysis. Diabetes Care January 1999 22:33-37; doi:10.2337/diacare.22.1.33

  4. Jörneskog, G

    • Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care January 1999 22:147-151; doi:10.2337/diacare.22.1.147

K

  1. Kalani, M

    • Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care January 1999 22:147-151; doi:10.2337/diacare.22.1.147

  2. Karlström, B E

    • Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care January 1999 22:10-18; doi:10.2337/diacare.22.1.10

  3. Kekäläinen, P

    • Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care January 1999 22:86-92; doi:10.2337/diacare.22.1.86

  4. Kidson, W

    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care January 1999 22:119-124; doi:10.2337/diacare.22.1.119

  5. Kitagawa, Y

    • Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care January 1999 22:152-156; doi:10.2337/diacare.22.1.152

  6. Kurimoto, Y

    • Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care January 1999 22:152-156; doi:10.2337/diacare.22.1.152

  7. Kushner, H

    • Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions. Diabetes Care January 1999 22:71-77; doi:10.2337/diacare.22.1.71

L

  1. Laakso, M

    • Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care January 1999 22:86-92; doi:10.2337/diacare.22.1.86

  2. Lavery, L A

    • Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care January 1999 22:157-162; doi:10.2337/diacare.22.1.157

  3. Leonnetti, D L

    • Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care January 1999 22:65-70; doi:10.2337/diacare.22.1.65

  4. Lièvre, M

    • Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care January 1999 22:178-179; doi:10.2337/diacare.22.1.178a

  5. Lipton, R B

    • Social environment and year of birth influence type 1 diabetes risk for African-American and Latino children. Diabetes Care January 1999 22:78-85; doi:10.2337/diacare.22.1.78

  6. Li, S

    • Social environment and year of birth influence type 1 diabetes risk for African-American and Latino children. Diabetes Care January 1999 22:78-85; doi:10.2337/diacare.22.1.78

  7. Lteif, A N

    • Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care January 1999 22:137-140; doi:10.2337/diacare.22.1.137

M

  1. Machecourt, J

    • Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care January 1999 22:19-26; doi:10.2337/diacare.22.1.19

  2. Marre, M

    • Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care January 1999 22:178-179; doi:10.2337/diacare.22.1.178a

  3. Marsh, J B

    • Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions. Diabetes Care January 1999 22:71-77; doi:10.2337/diacare.22.1.71

  4. Matyka, K A

    • Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Diabetes Care January 1999 22:27-32; doi:10.2337/diacare.22.1.27

  5. McElduff, A

    • Heterozygous hemoglobin Hamadan affects HbA1c assay. Diabetes Care January 1999 22:177; doi:10.2337/diacare.22.1.177

  6. McNeely, M J

    • Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care January 1999 22:65-70; doi:10.2337/diacare.22.1.65

  7. Meneilly, G S

    • Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care January 1999 22:112-118; doi:10.2337/diacare.22.1.112

  8. Moffitt, P

    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care January 1999 22:119-124; doi:10.2337/diacare.22.1.119

  9. Mohn, A

    • Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Diabetes Care January 1999 22:27-32; doi:10.2337/diacare.22.1.27

  10. Moore, W

    • Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diabetes Care January 1999 22:1-6; doi:10.2337/diacare.22.1.1

  11. Moses, R

    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care January 1999 22:119-124; doi:10.2337/diacare.22.1.119

  12. Muntoni, S

    • Metformin and fatty acids. Diabetes Care January 1999 22:179-180; doi:10.2337/diacare.22.1.179

N

  1. Namura, H

    • Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care January 1999 22:152-156; doi:10.2337/diacare.22.1.152

  2. Nitter-Hauge, S

    • Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care January 1999 22:45-49; doi:10.2337/diacare.22.1.45

O

  1. O'Shea, D

    • Lactic acidosis with therapeutic metformin blood level in a low-risk diabetic patient. Diabetes Care January 1999 22:178; doi:10.2337/diacare.22.1.178b

  2. Odekerken, D A

    • Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care January 1999 22:125-132; doi:10.2337/diacare.22.1.125

  3. Ostergren, J

    • Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care January 1999 22:147-151; doi:10.2337/diacare.22.1.147

P

  1. Pagano, G

    • Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care January 1999 22:50-55; doi:10.2337/diacare.22.1.50

  2. Pyörälä, K

    • Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care January 1999 22:86-92; doi:10.2337/diacare.22.1.86

R

  1. Rakic, M

    • Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care January 1999 22:125-132; doi:10.2337/diacare.22.1.125

  2. Ramachandran, A

    • GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years. Diabetes Care January 1999 22:175-176; doi:10.2337/diacare.22.1.175

  3. Rassam, A G

    • Optimal administration of lispro insulin in hyperglycemic type 1 diabetes. Diabetes Care January 1999 22:133-136; doi:10.2337/diacare.22.1.133

  4. Reiber, G E

    • Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care January 1999 22:157-162; doi:10.2337/diacare.22.1.157

  5. Rogantin, F

    • Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care January 1999 22:176-177; doi:10.2337/diacare.22.1.176a

  6. Rosenfield, R L

    • Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care January 1999 22:141-146; doi:10.2337/diacare.22.1.141

  7. Ross, K M

    • Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Diabetes Care January 1999 22:27-32; doi:10.2337/diacare.22.1.27

S

  1. Sandvik, L

    • Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care January 1999 22:45-49; doi:10.2337/diacare.22.1.45

  2. Sarlund, H

    • Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care January 1999 22:86-92; doi:10.2337/diacare.22.1.86

  3. Satyavani, K

    • GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years. Diabetes Care January 1999 22:175-176; doi:10.2337/diacare.22.1.175

  4. Schade, D S

    • Optimal administration of lispro insulin in hyperglycemic type 1 diabetes. Diabetes Care January 1999 22:133-136; doi:10.2337/diacare.22.1.133

  5. Schwenk, W F

    • Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care January 1999 22:137-140; doi:10.2337/diacare.22.1.137

  6. Selby, J V

    • First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization. Diabetes Care January 1999 22:38-44; doi:10.2337/diacare.22.1.38

  7. Sherif, K D

    • Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions. Diabetes Care January 1999 22:71-77; doi:10.2337/diacare.22.1.71

  8. Shofer, J B

    • Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care January 1999 22:65-70; doi:10.2337/diacare.22.1.65

  9. Sijbrands, E J

    • Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care January 1999 22:125-132; doi:10.2337/diacare.22.1.125

  10. Sikka, R

    • Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diabetes Care January 1999 22:1-6; doi:10.2337/diacare.22.1.1

  11. Silberbusch, J

    • Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care January 1999 22:125-132; doi:10.2337/diacare.22.1.125

  12. Sivasankari, S

    • GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years. Diabetes Care January 1999 22:175-176; doi:10.2337/diacare.22.1.175

  13. Slaats, E H

    • Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care January 1999 22:125-132; doi:10.2337/diacare.22.1.125

  14. Slobodniuk, R

    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care January 1999 22:119-124; doi:10.2337/diacare.22.1.119

  15. Smith, D G

    • Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care January 1999 22:157-162; doi:10.2337/diacare.22.1.157

  16. Smulders, Y M

    • Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care January 1999 22:125-132; doi:10.2337/diacare.22.1.125

  17. Snehalatha, C

    • GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years. Diabetes Care January 1999 22:175-176; doi:10.2337/diacare.22.1.175

  18. Stehouwer, C D

    • Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care January 1999 22:125-132; doi:10.2337/diacare.22.1.125

  19. Stolk, R P

    • Prevalence of deafness is increased in patients with type 2 diabetes in The Netherlands. Diabetes Care January 1999 22:180; doi:10.2337/diacare.22.1.180

  20. Sumner, A E

    • Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions. Diabetes Care January 1999 22:71-77; doi:10.2337/diacare.22.1.71

  21. Sutton, D R

    • Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diabetes Care January 1999 22:1-6; doi:10.2337/diacare.22.1.1

  22. Swain, B E

    • First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization. Diabetes Care January 1999 22:38-44; doi:10.2337/diacare.22.1.38

T

  1. Taketoh, H

    • Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care January 1999 22:152-156; doi:10.2337/diacare.22.1.152

  2. Taniguchi, T

    • Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care January 1999 22:152-156; doi:10.2337/diacare.22.1.152

  3. Thaulow, E

    • Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care January 1999 22:45-49; doi:10.2337/diacare.22.1.45

  4. Treskes, M

    • Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care January 1999 22:125-132; doi:10.2337/diacare.22.1.125

  5. Trovati, M

    • Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care January 1999 22:50-55; doi:10.2337/diacare.22.1.50

  6. Tulenko, T N

    • Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions. Diabetes Care January 1999 22:71-77; doi:10.2337/diacare.22.1.71

V

  1. Vanelli, M

    • Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care January 1999 22:7-9; doi:10.2337/diacare.22.1.7

  2. Vanzetto, G

    • Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care January 1999 22:19-26; doi:10.2337/diacare.22.1.19

  3. Veglio, M

    • Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care January 1999 22:50-55; doi:10.2337/diacare.22.1.50

  4. Vessby, B O

    • Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care January 1999 22:10-18; doi:10.2337/diacare.22.1.10

  5. Vijay, V

    • GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years. Diabetes Care January 1999 22:175-176; doi:10.2337/diacare.22.1.175

  6. Vileikyte, L

    • Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care January 1999 22:157-162; doi:10.2337/diacare.22.1.157

W

  1. Watanabe, N

    • Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care January 1999 22:152-156; doi:10.2337/diacare.22.1.152

  2. Waters, J

    • Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diabetes Care January 1999 22:1-6; doi:10.2337/diacare.22.1.1

  3. Weigle, D S

    • Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care January 1999 22:65-70; doi:10.2337/diacare.22.1.65

  4. Wendorf, M

    • Thrifty gene and hunting as a way of life are evident in a Paleoindian burial. Diabetes Care January 1999 22:176; doi:10.2337/diacare.22.1.176b

  5. Wollesen, F

    • Peripheral atherosclerosis and serum lipoprotein(a) in diabetes. Diabetes Care January 1999 22:93-98; doi:10.2337/diacare.22.1.93

Y

  1. Yamada, S

    • Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care January 1999 22:152-156; doi:10.2337/diacare.22.1.152

  2. Yoneda, N

    • Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care January 1999 22:152-156; doi:10.2337/diacare.22.1.152

Z

  1. Zeise, T M

    • Optimal administration of lispro insulin in hyperglycemic type 1 diabetes. Diabetes Care January 1999 22:133-136; doi:10.2337/diacare.22.1.133

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement